Peer-reviewed literature on the CyberKnife® System is accumulating rapidly. Below is a list of papers published in respected medical journals describing CyberKnife treatment throughout the body, along with a brief summary for each. Click on the links to see each paper’s full reference and abstract located online (most on PubMed, a medical research search site maintained by the U.S. National Library of Medicine and the National Institutes of Health).

Prostate

Robotic radiotherapy for prostate cancer with CyberKnife. Hannoun-Levi et al 2007. This article, in French, concludes that the CyberKnife System is a technical improvement to existing technology (HDR brachytherapy) for delivering a boost after EBRT.
Click here for full abstract

Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Fuller et al. 2008 Researchers from San Diego’s Radiosurgery Medial Group report that the CyberKnife System can achieve HDR-like dose distributions with excellent conformality and sharp dose fall off.
Click here for full abstract

Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial. King et al. 2008 Stanford University Researchers used the CyberKnife System to treat 41 low-risk prostate cancer patients.  With a median follow-up of 33 months they found no patient had a PSA failure.  They conclude that the early and late toxicity profile and PSA response for prostate treatment using the CyberKnife System are highly encouraging.
Click here for full abstract